Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation
  • Ask Questions

Events

Share this:

  • LinkedIn
  • Facebook
  • Twitter
  • WhatsApp
  • Skype
  • Email

Like this:

Like Loading...

Recent Posts

  • International Conference on Pharmaceutics and Drug Delivery Systems
  • Supreme delivery effect of β-cyclodextrin for hypoxic cancer cells recognized in 2019 Nobel prize laureate’s lab
  • European Symposium on Controlled Drug Delivery
  • A new multi-compendia modified beta-cyclodextrin, Kleptose® HPB-LB parenteral grade
  • Positive Results With SBECD-enabled Ganaxolone in Phase 2 Refractory Status Epilepticus Trial

Tags

antibiotic BBB Betadex Sulfobutyl Ether Sodium Biotechnology Book cancer Cancer therapy capillary electrophoresis Captisol Cholesterol Clinical trial conference Dexolve drug delivery Drugs Environment FDA Food HPBCD Nanoparticles Niemann Pick Niemann Pick Disease patent Polymer polyrotaxane SBECD Special issue Sugammadex Synthesis

Follow Us

  • LinkedIn
  • Twitter
  • Facebook

Categories

  • Agriculture (3)
  • Analysis (6)
  • CD as API (35)
  • CD derivatives (40)
  • Cosmetics and toilettry (7)
  • Drug delivery (66)
  • E-ducation (23)
  • Environmental (14)
  • Events (44)
  • Food (21)
  • Gene delivery (3)
  • Non-pharma applications (44)
  • Other industrial use (16)
  • Pharma applications (117)
  • Supramolecular systems (6)
  • Uncategorized (7)

Top Posts

  • International Cyclodextrin Symposium 2020
  • Supreme delivery effect of β-cyclodextrin for hypoxic cancer cells recognized in 2019 Nobel prize laureate's lab
  • FDA Approved Development of VAR 200 for Treatment of FSGS
  • Engineered cyclodextrin derivatives for spontaneous coating of highly porous metal-organic framework nanoparticles
  • The monograph of SBECD is official in the European Pharmacopeia
  • Cyclodextrins in doll-inspired nanostructures for cancer therapy
  • Sage Therapeutics Announces FDA Approval of ZULRESSO™ (SBECD-enabled brexanolone) Injection, the First and Only Treatment Specifically Indicated for Postpartum Depression
  • Novel polyrotaxane for Niemann Pick disease type C treatment
  • Positive Results With SBECD-enabled Ganaxolone in Phase 2 Refractory Status Epilepticus Trial
  • Protecting groups: Strategies and Applications in Carbohyrate Chemistry

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 157 other subscribers

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
%d bloggers like this: